Pharmacy

Your Article Summary

See Latest Articles

Certolizumab pegol (Cimzia): Anti-TNF-alpha mAb approved for the treatment of rheumatoid arthritis
Formulary , 06/10/09

Tumor necrosis factor (TNF)-alpha is a proinflammatory cytokine that plays a key role in inflammatory processes. Certolizumab is a humanized monoclonal antibody (mAb) that neutralizes TNF-alpha. This agent was approved on May 2009, for the treatment of adults with moderately to severely active rheumatoid arthritis.

Today in Drug Approvals...keeping you current

Receive free subspecialty "5-minute updates" via email

FDA Approves Gardasil to Prevent Genital Warts in Males. Agency Also Approves Bivalent HPV Vaccine for Girls, Young Women
American Family Physician, 10/22/09

Novartis receives FDA approval for Valturna®, a single-pill combination of valsartan and aliskiren, to treat high blood pressure
Novartis, 09/18/09

Salix Receives FDA Marketing Approval for Metozolv
Salix Pharmaceuticals, 09/10/09

See All of Drug Approvals

Today in Drug/Product Alerts...keeping you current

Receive free subspecialty "5-minute updates" via email

Salix Receives FDA Marketing Approval for Metozolv
Salix Pharmaceuticals, 09/10/09

Generic Anticonvulsant Use in Children: Do We Have Evidence to Recommend Brand Formulations?
Archives of Neurology, 11/23/09

FDA Grants Emergency Use Authorization of the Prodesse ProFlu-ST(TM)
Gen-Probe, 11/02/09

See All of Drug/Product Alerts

Today in Other Drugs...keeping you current

Receive free subspecialty "5-minute updates" via email

Doxycycline for osteoarthritis of the knee or hip
Cochrane Reviews, 10/23/09

Effect of Rosiglitazone, Metformin, and Glyburide on Bone Biomarkers in Patients with Type 2 Diabetes
Journal of Clinical Endocrinology and Metabolism, 11/10/09

A New Drug in a New Class for Postmenopausal Osteoporosis
The Female Patient, 11/11/09

See All of Other Drugs